Patents

Biomarker for diagnosing the effect of nervonic acid

ZL 202010816389.2

The biomarker that provided by this invention for the diagnosis of neurotic acid in Acer truncatum seed oil can be used to judge whether neurotic acid is absorbed and transformed by the body, and provide guidance for whether neurotic acid plays a role or not after using Acer truncatum seed oil.

Biomarker for diagnosing cognitive impairment and its application

ZL 202010816390.5

This invention provides a biomarker for diagnosing cognitive disorder, which is used to prepare a diagnostic reagent for diagnosing cognitive disorder, which is helpful for diagnosing whether there is a tendency of cognitive disorder and preventing it in advance.

Biomarkers for diagnosing white matter lesions and its applications

ZL 202110352946.4

This invention provides a biomarker for diagnosing white matter lesions, which is used to prepare diagnostic reagents for predicting or diagnosing white matter lesions, which is helpful for diagnosing whether there is a tendency for white matter lesions and preventing them in advance.

Biomarker F7 for diagnosing white matter lesions and its application

ZL 202110385946.4

This invention provides a biomarker for diagnosing white matter lesions, which is used to prepare diagnostic reagents for predicting or diagnosing white matter lesions, which is helpful for diagnosing whether there is a tendency for white matter lesions and preventing them in advance.

Biomarker for diagnosing cognitive impairment and its application

ZL 202010816217.5

This invention provides a biomarker for diagnosing cognitive disorder, which is used to prepare a diagnostic reagent for diagnosing cognitive disorder, which is helpful for diagnosing whether there is a tendency of cognitive disorder and preventing it in advance.